Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -31.32% is 460% below its 5-year average of 8.69%, near the low end of its 5-year range (-31.32%–39.32%).
As of the fiscal period ended Tuesday, June 30, 2026. 529.48% below its 12-month average of -4.97%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -31.32%.
RETURN ON EQUITY (ROE)
-31.32%
RETURN ON EQUITY (ROE) AVG TTM
-4.97%
RETURN ON EQUITY (ROE) AVG 3Y
0.47%
RETURN ON EQUITY (ROE) AVG 5Y
8.69%
RETURN ON EQUITY (ROE) AVG 10Y
0.45%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-529.48%
CURRENT VS 3Y AVG
-6706.96%
CURRENT VS 5Y AVG
-460.29%
CURRENT VS 10Y AVG
-7024.25%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
+25.46%
vs the sector median at left
Organogenesis Holdings Inc.
Market Cap
$172.42M
Return on Equity (ROE)
-31.32%
TTM Avg
-4.97%
3Y Avg
0.47%
5Y Avg
8.69%
Market Cap
$171.13M
Return on Equity (ROE)
-116.42%
TTM Avg
-18.43%
3Y Avg
-136.68%
5Y Avg
-137.61%
Market Cap
$173.76M
Return on Equity (ROE)
-54.27%
TTM Avg
-50.07%
3Y Avg
-62.91%
5Y Avg
-60.87%
Market Cap
$174.27M
Return on Equity (ROE)
-84.80%
TTM Avg
-85.93%
3Y Avg
-69.58%
5Y Avg
-185.12%
Market Cap
$169.53M
Return on Equity (ROE)
-19.01%
TTM Avg
-54.50%
3Y Avg
-75.60%
5Y Avg
-59.28%
Market Cap
$168.92M
Return on Equity (ROE)
-56.61%
TTM Avg
-75.88%
3Y Avg
-88.15%
5Y Avg
-30.55%
Market Cap
$168.10M
Return on Equity (ROE)
-7104.24%
TTM Avg
-166.54%
3Y Avg
-137.65%
5Y Avg
-112.46%
Market Cap
$179.26M
Return on Equity (ROE)
55.08%
TTM Avg
9.52%
3Y Avg
-0.62%
5Y Avg
-4.34%
Market Cap
$165.32M
Return on Equity (ROE)
3.51%
TTM Avg
-6.60%
3Y Avg
-9.04%
5Y Avg
-6.71%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Organogenesis Holdings Inc. (ORGO) | $172.42M | -31.32% | -4.97% | 0.47% | 8.69% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -116.42% | -18.43% | -136.68% | -137.61% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -54.27% | -50.07% | -62.91% | -60.87% |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | -84.80% | -85.93% | -69.58% | -185.12% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -19.01% | -54.50% | -75.60% | -59.28% |
| MediWound Ltd. (MDWD)vs › | $168.92M | -56.61% | -75.88% | -88.15% | -30.55% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -7104.24% | -166.54% | -137.65% | -112.46% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | 55.08% | 9.52% | -0.62% | -4.34% |
| OptimizeRx Corp. (OPRX)vs › | $165.32M | 3.51% | -6.60% | -9.04% | -6.71% |
| Nkarta, Inc. (NKTX)vs › | $165.27M | -47.36% | -30.00% | -33.39% | -32.72% |
ROE
-31.3%
ROA
-22.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -31.32% |
| 2026-03-31 | -0.07% |
| 2025-12-31 | 8.53% |
| 2025-09-30 | 0.26% |
| 2025-06-30 | -2.28% |
| 2025-03-31 | -4.31% |
| 2024-12-31 | 0.22% |
| 2024-09-30 | -2.65% |
| 2024-06-30 | -6.28% |
| 2024-03-31 | 2.09% |
| 2023-12-31 | 1.77% |
| 2023-09-30 | 4.70% |
| 2023-06-30 | 3.70% |
| 2023-03-31 | 5.11% |
| 2022-12-31 | 5.85% |
| 2022-09-30 | 23.31% |
| 2022-06-30 | 28.34% |
| 2022-03-31 | 34.55% |
| 2021-12-31 | 39.32% |
| 2021-09-30 | 32.62% |
| 2021-06-30 | 39.06% |
| 2021-03-31 | 27.99% |
| 2020-12-31 | 12.53% |
| 2020-09-30 | -7.82% |
| 2020-06-30 | -102.43% |
| 2020-03-31 | -102.00% |
| 2019-12-31 | -72.78% |
| 2019-09-30 | -353.77% |
| 2019-06-30 | -127.74% |
| 2019-03-31 | -60.28% |
| 2018-12-31 | -8.71% |
| 2018-09-30 | 1.54% |
| 2018-06-30 | -0.80% |
| 2018-03-31 | -0.80% |
| 2017-12-31 | -0.70% |
| 2017-09-30 | -0.59% |
| 2017-06-30 | 0.11% |
| 2017-03-31 | -0.02% |
| 2016-12-31 | -0.07% |
